Correlation Between Edgewise Therapeutics and PepGen
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and PepGen, you can compare the effects of market volatilities on Edgewise Therapeutics and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and PepGen.
Diversification Opportunities for Edgewise Therapeutics and PepGen
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and PepGen is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and PepGen go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and PepGen
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.39 times more return on investment than PepGen. However, Edgewise Therapeutics is 2.58 times less risky than PepGen. It trades about -0.11 of its potential returns per unit of risk. PepGen is currently generating about -0.35 per unit of risk. If you would invest 3,404 in Edgewise Therapeutics on August 28, 2024 and sell it today you would lose (206.00) from holding Edgewise Therapeutics or give up 6.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. PepGen
Performance |
| Timeline |
| Edgewise Therapeutics |
| PepGen |
Edgewise Therapeutics and PepGen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and PepGen
The main advantage of trading using opposite Edgewise Therapeutics and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| PepGen vs. Pmv Pharmaceuticals | PepGen vs. Eliem Therapeutics | PepGen vs. MediciNova | PepGen vs. Pharvaris BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |